BioSpace News Archive

Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech solutions company, have announced a strategic partnership to bring Brainomix’s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world.

Small Pharma Inc. today announces that SPL026, intravenous N,N-Dimethyltryptamine (“DMT”), with supportive therapy for the treatment of Major Depressive Disorder (“MDD”) met the primary endpoint in its Phase IIa clinical trial, demonstrating a statistically significant and clinically relevant reduction in depressive symptoms at two-weeks post-dose, as compared to placebo.

POXEL SA announced that European Commission has granted orphan drug designation for PXL770 and PXL065 for the treatment of adrenoleukodystrophy.

Sedana Medical AB announced on 19 January 2023 that Nasdaq Stockholm’s listing committee had resolved to approve the Company’s application for admission to trading of the Company’s shares on Nasdaq Stockholm.

Immuron Limited today announces that a response letter has been submitted to the US Food and Drug Administration (FDA). Immuron has previously reported feedback was received from the FDA following a review of the Investigational New Drug (IND) application (ASX announcement July 26, 2022) of a new oral therapeutic targeting Campylobacter and ETEC developed in collaboration with Immuron.

Bioinformatic experts at Singleron Biotechnologies , a leader in single cell sequencing, have developed a new single cell eQTL analysis workflow that takes advantage of single cell RNA sequencing (scRNAseq) and whole genome sequencing (WGS) data to predict cell-type specific eQTLs.

Collaboration to seed critical progress in radiation oncology for patients with lung cancer.

RION, a clinical-stage regenerative medicine company with breakthrough platform technology leveraging platelet-derived exosomes, announces the appointment of Dr. Ballantyne as Chair of the company’s Scientific Advisory Board and Dr. Andrew D. Badley as Chair of the Rion Medical Advisory Board.

Continuing a long-term commitment to improving outcomes for lung cancer patients by supporting the next generation of lung cancer researchers, LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit, has issued five Requests for Application (RFAs).

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its third annual cybersecurity report to update stakeholders about the company’s ongoing efforts to advance cybersecurity maturity, protect against cyberattacks and empower customers with information about cyber risks and vulnerabilities.